Jack W. Singer, EVP, Global Medical Affairs at CTI BIOPHARMA CORP (CTIC), sold 161,570 shares at $1.94 ($313K) on 2015-03-20, disclosed to the SEC on 2015-03-24.
Scheduled sale ($313k) by EVP, Global Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.92 | 6,700 | $13K | 4.1% |
| 2 | $1.93 | 16,200 | $31K | 10.0% |
| 3 | $1.94 | 2,900 | $6K | 1.8% |
| 4 | $1.94 | 18,600 | $36K | 11.5% |
| 5 | $1.95 | 19,600 | $38K | 12.2% |
| 6 | $1.96 | 3,600 |
| $7K |
| 2.3% |
| 7 | $1.94 | 93,970 | $182K | 58.2% |
| Total | $1.94 avg | 161,570 | $313K | 100% |
| Filing → |
| CTIC | SELL | 2015-12-18 | $18K | — | Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |